Seoul National University Hospital
Seoul, Jongnogu, 03080, South Korea
NCT Number: NCT04456166
The purpose of this study is to investigate the safety of preoperative carbohydrate loading in diabetic patients undergoing general anesthesia
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Seoul, Jongnogu, 03080, South Korea
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients with diabetes mellitus type 2 who are planned to receive a carbohydrate beverage (400 ml (12.8% carbohydrates, 50 kcal/100 ml; Nucare NONPO Ⓡ , Daesang Wellife, Korea) before the operation and up to 2 hours before the induction of anesthesia outside this clinical study setting will be asked to be enrolled into the study.
Before induction of general anesthesia, all patients were evaluated the gastric volume under ultrasonography.
Time frame: 30 minutes after intubation
Ultrasound assessment of gastric volume by gastroscopic examination.
Time frame: 30 minutes after intubation
Time frame: 30 minutes after intubation and 30 minutes after extubation
Time frame: during operation
Time frame: up to 30 minutes after extubation
Time frame: up to 30 minutes after extubation
Time frame: up to 30 minutes after extubation
Seoul National University Hospital
Other
Safety of Preoperative Carbohydrate Loading in Diabetic Patients Undergoing General Anesthesia
Acronym: NoNPO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04656210
Carbohydrate Intolerance, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Lille, France
View Trial DetailsNCT03667963
Carbohydrate Intolerance, Glucose-Galactose Malabsorption
Toronto, Ontario, Canada
View Trial DetailsNCT03506581
BETA-CELL FUNCTION, Body Composition
View Trial DetailsNCT03138902
Carbohydrate Intolerance, Glucose-Galactose Malabsorption
View Trial Details